866-274-4009 Contact Us

News & Media

Recent Press

Center for Breakthrough Medicines Adds Two Senior Vice Presidents to Leadership Team

The Center for Breakthrough Medicines (CBM) in partnership with the Discovery Labs announced today the acceleration of plans to build capacity to manufacture more than 10,000 patient therapies in direct response to the critical shortage of cell therapy supply, which will help patients win their courageous battles against cancer.

July 27, 2022

Center for Breakthrough Medicines Accelerates Plans to Build the Largest Cell Therapy Manufacturing Operation in the World

The Center for Breakthrough Medicines (CBM) in partnership with the Discovery Labs announced today the acceleration of plans to build capacity to manufacture more than 10,000 patient therapies in direct response to the critical shortage of cell therapy supply, which will help patients win their courageous battles against cancer.

June 13, 2022

iECURE Enters Agreement with Center for Breakthrough Medicines (CBM) to Supply Materials for Future Clinical Programs

iECURE, a gene editing company focused on mutation-agnostic in vivo gene insertion, or knock-in, editing for the treatment of liver disorders with significant unmet need, and Center for Breakthrough Medicines (CBM) today announced the companies have entered into a strategic collaboration wherein CBM will produce and supply Good Manufacturing Practices (GMP)-grade adeno-associated virus (AAV) for use in iECURE’s future clinical studies to enable development of iECURE’s programs with the shared mission of accelerating the availability of these potential treatments to the patients.

May 25, 2022

The Center for Breakthrough Medicines (CBM) Strikes Multi-Year Deal with UK Cell Therapy Powerhouse

Strategic Partnership to Deliver US Based Manufacturing Capacity for Novel Cell Therapy King of Prussia

April 12, 2022

Center for Breakthrough Medicines Launches Analytical Testing Services for Advanced Therapies, Bringing Solutions to a Supply-Constrained Industry

Testing Business Unit Will Grow to More Than 400 Employees, Eliminate Wait Times, and Enable Faster Release Times…

February 16, 2022

The Center for Breakthrough Medicines and the University of Pennsylvania Partner in the Manufacturing of Gene Therapies

— Penn’s Innovation in Process Science Combines with CBM Manufacturing Capability to Develop Large-Scale Gene Therapy…

January 18, 2022